Quantifying the Impact of Persistent Musculoskeletal Pain on Employees at Rolls-Royce: A Cross-Sectional Survey

Author(s)

Abraham L1, Russell R2, Sanchez-Riera L1, Emir B3, Roomes D4, Green K4, Taylor-Stokes G5, Mirams L6, Wallis H7, Burton K8
1Pfizer Ltd, Tadworth, Surrey, SRY, UK, 2Pfizer Ltd, Tadworth, SRY, UK, 3Pfizer, Inc, New York, NY, USA, 4Rolls Royce, Derby, DBY, UK, 5Adelphi Real World, LONDON, CHE, Great Britain, 6Adelphi Real World, Manchester, CHE, UK, 7Adelphi Real World, Bollington, CHE, UK, 8Centre for Applied Research in Health, Huddersfield, UK

Presentation Documents

OBJECTIVES: We aimed to investigate the impact of persistent musculoskeletal (MSK) pain on Rolls-Royce employees, including work ability (WA), sickness absence and emotional well-being. Employee perceptions of workplace culture were also examined.

METHODS: Data from Rolls-Royce employees were collected via an online cross-sectional survey conducted in the United Kingdom in 2021 (response rate = 5.60%). Two groups (based on self-reported experience of persistent MSK pain/no pain) were compared using weighted regression analysis with Inverse Probability of Treatment Weighting controlling for confounding variables such as age and sex. Outcome variables included number of sickness absence days and ratings of overall WA (from 0-10), WA with respect to the physical/psychological demands of work and anxiety/depression experienced over the past month. The impact of different types of MSK pain (joint, back, neck, tendon or muscle pain) was also investigated by comparing employees with and without each type of pain.

RESULTS: Employees with pain (n=298, 78% male) vs without pain (n= 329, 75% male) took significantly more days off work in the past 3 months due to pain (3.9 vs 0.5 days, p<0.01), reported significantly lower WA overall (8.1 vs 9.0, p<0.001) and with respect to the physical demands of work with 41% (vs. 72%) providing a rating of ‘very good’ (p<0.001). In total, 56% of employees with pain had not told their managers about their pain; with 30% of these feeling uncomfortable doing so, and 19% feeling that they did not have sufficient support at work for their pain.

CONCLUSIONS: The finding that persistent MSK pain had a significant impact on sickness absence and WA, but was underreported, highlights the importance of going beyond occupational health provision to create a workplace culture that encourages employees to disclose their work-relevant pain, enabling organisations to consider improved, tailored support for their employees.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

OP6

Topic

Organizational Practices

Topic Subcategory

Industry

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×